Fol. Biol. 2012, 58, 209-214
https://doi.org/10.14712/fb2012058050209
Transcriptional Activity of Tumour Necrosis Factor α (TNF‐α) in Patients with Subclinical Coronary Atherosclerosis – Preliminary Results
References
1. , M., Rabkin, E., Sugiyama, S., Voglic, S. J., Fukumoto, Y., Furukawa, Y., Shiomi, M., Schoen, F. J., Libby, P. (2001) An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation 103, 276-283.
<https://doi.org/10.1161/01.CIR.103.2.276>
2. , Y., Goodman, K. J., Roth, M., Newstein, D., Guerci, A. D. (2005) Coronary calcification, coronary disease risk factors, C‐reactive protein, and atherosclerotic cardiovascular disease events: the St Francis Heart Study. J. Am. Coll. Cardiol. 46, 158-165.
<https://doi.org/10.1016/j.jacc.2005.02.088>
3. , E., Carnevale Schianca, G. P., Sainaghi, P. P. (2010) Treating high blood pressure: is reaching the target more important than the means? Yes, the target is more important. Eur. J. Intern. Med. 21, 473-477.
<https://doi.org/10.1016/j.ejim.2010.09.016>
4. , E., Bea, F., Kuo, C. C., Campbell, L. A., Chesebro, B., Rosenfeld, M. E. (2004) Lesion progression and plaque composition are not altered in older apoE-/- mice lacking tumor necrosis factor‐a receptor p55. Atherosclerosis 176, 227-232.
<https://doi.org/10.1016/j.atherosclerosis.2004.05.033>
5. , L. S., Zadelaar, A. S., van Nieuwkoop, A., Gijbels, M. J., de Winther, M. P., Havekes, L. M., van Vlijmen, B. J. (2005) Tumor necrosis factor-α promotes atherosclerotic lesion progression in APOE*3-Leiden transgenic mice. Cardiovasc. Res. 66, 179-185.
<https://doi.org/10.1016/j.cardiores.2005.01.001>
6. , L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., Jovinge, S. (2004) Inhibition of tumour necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 24, 2137-2142.
<https://doi.org/10.1161/01.ATV.0000143933.20616.1b>
7. , E. R., Kronmal, R. A., Bluemke, D. A., Guerci, A. D., Carr, J. J., Goldin, J., Detrano, R. (2008) Coronary calcium coverage score: determination, correlates, and predictive accuracy in the Multi‐Ethnic Study of Atherosclerosis. Radiology 247, 669-675.
<https://doi.org/10.1148/radiol.2473071469>
8. , A. I., Lampa, J., Ernestam, S., af Klint, E., Bratt, J., Klareskog, L., Ulfgren, A. K. (2002) Antitumour necrosis factor (TNF)-α therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis. Rheumatology 41, 484-489.
<https://doi.org/10.1093/rheumatology/41.5.484>
9. , M., Gerstein, H. C., Wang, Y., Yusuf, S. (1999) The relationship between glucose and incident cardiovascular events: a meta regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22, 233-240.
<https://doi.org/10.2337/diacare.22.2.233>
10. , K. S., Gotlieb, A. I. (2005) The role of shear stress in the pathogenesis of atherosclerosis. Lab. Invest. 85, 9-23.
<https://doi.org/10.1038/labinvest.3700215>
11. C. A. (2009) Immunological and inflammatory functions of the interleukin‐1 family. Annu. Rev. Immunol. 27, 519-550.
<https://doi.org/10.1146/annurev.immunol.021908.132612>
12. , L., Garcia‐Alvarez, A., Bagheriannejad-Esfahani, F., Malick, W., Mirelis, J. G., Sawit, S. T., Fuster, V., Sanz, J., Garcia, M. J., Hermann, L. K. (2011) Diagnostic value of coronary artery calcium scoring in low‐intermediate risk patients evaluated in the emergency department for acute coronary syndrome. Am. J. Cardiol. 107, 17-23.
<https://doi.org/10.1016/j.amjcard.2010.08.037>
13. , P., LaBree, L., Azen, S. P., Doherty, T. M., Detrano, R. C. (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 291, 210-215.
<https://doi.org/10.1001/jama.291.2.210>
14. , C., Dimmeler, S., Hamm, C. W., van den Brand, M. J., Boersma, E., Zeiher, A. M., Simoons, M. L., CAPTURE Study Investigators. (2003) Soluble CD40 ligand in acute coronary syndromes. N. Engl. J. Med. 348, 1104-1111.
<https://doi.org/10.1056/NEJMoa022600>
15. , L. T., Turesson, C., Gulfe, A., Kapetanovic, M. C., Petersson, I. F., Saxne, T., Geborek, P. (2005) Treatment with tumour necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J. Rheumatol. 32, 1213-1218.
16. , Y., Lincoff, A. M., Plow, E. F., Topol, E. J. (1994) Cell adhesion molecules in coronary artery disease. J. Am. Coll. Cardiol. 24, 1591-1601.
<https://doi.org/10.1016/0735-1097(94)90162-7>
17. , R., Salehi, A., Tarzamni, M. K., Aslanabadi, N., Pak, N. (2010) Diagnostic efficacy of coronary calcium score in the assessment of significant coronary artery stenosis. Kardiol. Pol. 68, 285-291.
18. , J., Merasto, S., Paakkari, I., Mervaala, E. M. (2005) High sodium intake increases superoxide formation and promotes atherosclerosis in apolipoprotein E-deficient mice. Blood Press. 14, 373-382.
<https://doi.org/10.1080/08037050500383687>
19. , C. J., Law, R. E., Hsueh, W. A. (2003) Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 144, 2195-2200.
<https://doi.org/10.1210/en.2003-0285>
20. , F., Loetscher, H., Stueber, D., Gehr, G., Lesslauer, W. (1993) Tumour necrosis factor α (TNFα)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF‐R55. J. Exp. Med. 177, 1277-1286.
<https://doi.org/10.1084/jem.177.5.1277>
21. , M. F., Meijboom, W. B., Prokop, M., Mollet, N. R., van Mieghem, C. A., Doevendans, P. A., de Feyter, P. J., Cramer, M. J. (2009) Is there a role for CT coronary angiography in patients with symptomatic angina? Effect of coronary calcium score on identification of stenosis. Int. J. Cardiovasc. Imaging 25, 847-854.
<https://doi.org/10.1007/s10554-009-9485-7>
22. , A. H., Boer, J. M., Schouten, L. J., Feskens, E. J., Verschuren, W. M., Gorgels, A. P., van den Brandt, P. A. (2011) Smoking, alcohol consumption, physical activity, and family history and the risks of acute myocardial infarction and unstable angina pectoris: a prospective cohort study. BMC Cardiovasc. Disord. 11, 13.
<https://doi.org/10.1186/1471-2261-11-13>
23. , N., Bermudez‐Fajardo, A., Penichet, M. L., OviedoOrta, E. (2008) Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Clin. Dev. Immunol. 2008, 723539.
<https://doi.org/10.1155/2008/723539>
24. , H., Wada, H., Niwa, T., Kirii, H., Iwamoto, N., Fujii, H., Saito, K., Sekikawa, K., Seishima, M. (2005) Disruption of tumor necrosis factor-α gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 180, 11-17.
<https://doi.org/10.1016/j.atherosclerosis.2004.11.016>
25. , M., Stillman, A. E., Halliburton, S. S., Kalender, W. A., Möhlenkamp, S., McCollough, C. H., Vliegenthart, R., Shaw, L. J., Stanford, W., Taylor, A. J., van Ooijen, P. M., Wexler, L., Raggi, P. (2008) Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int. J. Cardiovasc. Imaging 24, 645-671.
<https://doi.org/10.1007/s10554-008-9319-z>
26. , S., Negassa, A., Yusuf, S. (2001) INTER-HEART: A global study of risk factors for acute myocardial infarction. Am. Heart J. 141, 711-721.
<https://doi.org/10.1067/mhj.2001.114974>
27. , M. I., Koskinas, K. C., Chatzizisis, Y. S., Stone, P. H., Feldman, C. L. (2010) In-vivo assessment of the natural history of coronary atherosclerosis: vascular remodeling and endothelial shear stress determine the complexity of atherosclerotic disease progression. Curr. Opin. Cardiol. 25, 627-638.
<https://doi.org/10.1097/HCO.0b013e32833f0236>
28. , P. M., Rifai, N., Pfeffer, M., Sacks, F., Lepage, S., Braunwald, E. (2000) Elevation of tumour necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation 101, 2149-2153.
<https://doi.org/10.1161/01.CIR.101.18.2149>
29. , A., Pulkki, K., Kallajoki, M., Henriksen, K., Parvinen, M., Voipio-Pulkki, L. M. (1997) Apoptosis in human acute myocardial infarction. Circulation 95, 320-323.
<https://doi.org/10.1161/01.CIR.95.2.320>
30. , S. A., Peschon, J. J., LeBoeuf, R. C. (1996) Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J. Biol. Chem. 271, 26174-26178.
<https://doi.org/10.1074/jbc.271.42.26174>
31. , P., Corallini, F., Ceconi, C., Parrinello, G., Volpato, S., Ferrari, R., Zauli, G. (2009) Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction. PLoS One, 4, e4442.
<https://doi.org/10.1371/journal.pone.0004442>
32. , R. K., Sharma, R. K., Voelker, D. J., Singh, V. N., Pahuja, D., Nash, T., Reddy, H. K. (2010) Cardiac risk stratification: role of the coronary calcium score. Vasc. Health Risk Manag. 6, 603-611.
<https://doi.org/10.2147/VHRM.S8753>
33. T. H. (2005) TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23, 23-68.
<https://doi.org/10.1146/annurev.immunol.23.021704.115839>
34. , D., Taylor, W. R. (2008) Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension 51, 218-224.
<https://doi.org/10.1161/HYPERTENSIONAHA.107.095885>
35. , S., Thelen, M., Pöttgens, C., Gijbels, M. J., Lutgens, E., de Winther, M. P. (2009) Absence of p55 TNF receptor reduces atherosclerosis, but has no major effect on angiotensin II induced aneurysms in LDL receptor deficient mice. PLoS One 4, e6113.
<https://doi.org/10.1371/journal.pone.0006113>
